Nizameddin KOCA, Yasemin ÜSTÜNDAĞ, Abdullah ŞİMŞEK, Hülya PARILDAR, Kağan HUYSAL, Ali ASAN, Burcu Dalyan CİLO, Halil Erkan SAYAN

Do initial hematologic indices predict the severity of COVID-19 patients?

Background/aim: In this study, we aimed to evaluate the initial hematological findings analyzed on admission in confirmed COVID-19 patients who were transferred to the intensive care unit (ICU), to predict possible hematological indices. Materials and methods: Initial neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), monocyte to lymphocyte ratio (MLR), red cell distribution width to platelet ratio (RPR), mean platelet volume to platelet ratio, and lymphocyte multiplied by platelet count (LYM × PLT), of 695 patients with laboratory-confirmed COVID-19 were investigated and comparisons were made between the mild/moderate and severe groups. Results: The proportion of COVID-19 cases admitted to the ICU was 3.9%. The median age of patients admitted to the ICU was significantly higher than those who were not; [68.5 (interquartile range (IQR); 21.5] years vs. 41.0 (IQR; 15.7) years; P < 0.001. Severe cases had higher NLR (6.6 vs. 2.4; P < 0.001), and MLR (0.40 vs. 0.28; P = 0.004) and lower PLR (180.0 vs. 129.0; P < 0.001) compared to that of mild or moderate patients. Among all of the parameters, the ROC curve of NLR gave us the best ability to distinguish serious patients at an early stage (AUC = 0. 819, 95% confidence interval 0.729–0.910; P < 0.001). Conclusion: These data showed that age, initial NLR, PLR, and LYM × PLT were associated with the severity of COVID-19 disease and patients’ need for the ICU. Therefore, initial hemogram parameters may be essential to predict the prognosis of COVID-19 patients.Key words: Intensive care unit, COVID-19, neutrophils, leukocytes, platelets

PDF

___

1. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. JAMA: The Journal of the American Medical Association 2020; 323(11): 1061-1069. doi: 10.1001/jama.2020.1585
2. Huang C, Wang Y, Li X, Ren N, Zhao Jet al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497‐506. doi: 10.1016/S0140- 6736(20)30183-5.
3. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: Early experience and forecast during an emergency response. JAMA: The Journal of the American Medical Association 2020. doi:10.1001/ jama.2020.4031
4. Qin C, Zhou L, Hu Z, Zhang S, Yang S et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2020; 71 (15): 762- 768. doi: 10.1093/cid/ciaa248
5. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. The Journal of Infection 2020; 80 (6): 607‐613. doi: 10.1016/j.jinf.2020.03.037
6. Cai J, Wang K, Han T, Jiang H. Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2018;97 (46): e13324. doi: 10.1097/MD.0000000000013324
7. Russell CD, Parajuli A, Gale HJ, Bulteel NS, Schuetz P et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: a systematic review and meta-analysis. The Journal of Infection 2019;78 (5): 339‐348. doi: 10.1016/j. jinf.2019.02.006
8. Liu Z, Li X, Zhang M, Huang X, Bai Jet al. The role of mean platelet volume/platelet count ratio and neutrophil to lymphocyte ratio on the risk of febrile seizure. Scientific Reports 2018; 8: 15123. doi: 10.1038/s41598-018-33373-3
9. Fei Y, Zhang H, Zhang C. The application of lymphocyte*platelet and mean platelet volume/platelet ratio in influenza A infection in children. Journal of Clinical Laboratory Analysis 2019; 33 (9): e22995. doi: 10.1002/jcla.22995
10. Fu L, Wang B, Yuan T, Chen X, Ao Y et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. The Journal of Infection 2020; 80 (6): 656-665. doi: 10.1016/j.jinf.2020.03.041
11. Sun S, Cai X, Wang H, He G, Lin Yet al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica Chimica Acta: International Journal of Clinical Chemistry 2020; 507: 174-180. doi: 10.1016/j. cca.2020.04.024
12. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica Chimica Acta: International Journal of Clinical Chemistry 2020; 506: 145‐148. doi: 10.1016/j. cca.2020.03.022
13. Tan L, Wang Q, Zhang D, Ding J, Huang Q et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduction and Targeted Therapy 2020; 5: 33. doi: 10.1038/s41392-020-0148-4
14. Terpos, E, Ntanasis‐Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN et al. Hematological findings and complications of COVID‐19. American Journal of Hematology 2020; 95(7): 834-847. doi: 10.1002/ajh.25829
15. Cetinkaya E, Senol K, Saylam B, Tez M. Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World Journal of Gastroenterology 2014; 20 (39): 14450‐14454. doi: 10.3748/wjg.v20.i39.14450
16. Huang G, Kovalic AJ, Graber CJ. Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity. Emerging Infectious Diseases 2020; 26 (8): 1839-1841. doi: 10.3201/eid2608.201160
17. Shang W, Dong J, Ren Y, Tian M, Li W et al. The value of clinical parameters in predicting the severity of COVID-19. Journal of Medical Virology 2020. doi: 10.1002/jmv.26031
18. Naumenko V, Turk M, Jenne CN, Kim SJ. Neutrophils in viral infection. Cell and Tissue Research 2018; 371 (3): 505‐516. doi: 10.1007/s00441-017-2763-0
19. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology 2017; 3: 529-539. doi: 10.1007/s00281-017-0629-x
20. Bellelli V, d’Ettorre G, Celani L, Borrazzo C, Ceccarelli G et al. Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virus. Critical Care 2019; 23: 330. doi: 10.1186/s13054-019-2608-1
21. Gu J, Gong E, Zhang B, Zheng J, Gao Z et al. Multiple organ infection and the pathogenesis of SARS. The Journal of Experimental Medicine 2005; 202: 415-424. doi: 10.1084/ jem.20050828
22. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International Immunopharmacology 2020; 84: 106504. doi: 10.1016/j.intimp.2020.106504
23. Ding X, Yu Y, Lu B, Huo J, Chen M et al. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019. Clinical Chemistry and Laboratory Medicine 2020. doi: 10.1515/cclm2020-0411
24. Zarychanski R, Houston DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematology, American Society of Hematology Education Program 2017; 2017: 660-666. doi: 10.1182/asheducation-2017.1.660
25. Liu Y, Sun W, Guo Y, Chen L, Zhang L et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets 2020; 31 (4): 490-496. doi: 10.1080/09537104.2020.1754383
26. Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 2005; 10: 101-105. doi: 10.1080/10245330400026170
27. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ et al. Clinical characteristics of Coronavirus disease 2019 in China. The New England Journal of Medicine 2020; 382 (18): 1708‐1720. doi: 10.1056/NEJMoa2002032
28. Yang X, Yu Y, Xu J, Shu H, Xia J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine 2020; 8 (5): 475‐481. doi: 10.1016/S2213-2600(20)30079-5
29. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA: The Journal of the American Medical Association 2020; 323 (15): 1488‐1494. doi: 10.1001/jama.2020.3204
30. Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Archives of Pathology and Laboratory Medicine 2009; 133 (4): 628‐632. doi: 10.1043/1543-2165-133.4.628
31. He Y, Liu C, Zeng Z, Ye W, Lin J et al. Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis. ClinicalRheumatology 2018; 37 (1): 161‐167. doi: 10.1007/s10067-017-3871-7
32. Bazick HS, Chang D, Mahadevappa K, Gibbons FK, Christopher KB. Red cell distribution width and all-cause mortality in critically ill patients. Critical Care Medicine 2011; 39 (8): 1913‐1921. doi: 10.1097/CCM.0b013e31821b85c6